MKD @ 127.0.0.1 2x💉 🍉

5.3K posts

MKD @ 127.0.0.1 2x💉 🍉 banner
MKD @ 127.0.0.1 2x💉 🍉

MKD @ 127.0.0.1 2x💉 🍉

@decode_dev

Speaker 🎙️@mozTechSpeakers • Security 🤓 • ❤️ ✈️🚞🚝 • Gamer 🎮 • ❤️ to 🔨things to 👷 again • He / him

null | void Katılım Kasım 2014
2K Takip Edilen405 Takipçiler
MKD @ 127.0.0.1 2x💉 🍉
@gethackteam Razor is like 4x Logitech worst in terms of their mouse applications. Like just keep the colors + settings & variations in one app along with hotkeys. Nope 🙃
English
1
0
0
22
Roy Derks 🚀
Roy Derks 🚀@gethackteam·
logitech must have the worst software strategy ever i love their devices, but everyone time they stop working as expected it turns out they have a new "app" to configure them logitech ghub logitech options logitech options+ logitech control center logitech control app when will it stop?
English
3
0
7
781
Ashish K. Mishra
Ashish K. Mishra@akm1410·
AI is now taking a serious chunk out of Indian IT companies revenue. A fact that they are still underestimating and talking in only vague terms. Latest is that TCS's biggest contract renewals will be at a significant haircut than before. @MorningContext
Ashish K. Mishra tweet mediaAshish K. Mishra tweet media
English
5
7
17
3K
MKD @ 127.0.0.1 2x💉 🍉
@neilghosh Haha. Seeing Gemini de-gradation is something I didn’t expect. Even the flash + flash-extended doesn’t seem to work for even simpler tasks. Pro is token hungry. Working out some stuff on OSS MML. Okay to Ping on Sig or WA?
English
0
0
0
22
Neil Ghosh
Neil Ghosh@neilghosh·
@decode_dev GitHub Copilot ( unlimited from work ) . Ran out of AI credit in antigravity cli within an hour despite “pro” plan.
English
1
0
1
43
Neil Ghosh
Neil Ghosh@neilghosh·
LLMs are great at connecting the dots. Tax filing
Neil Ghosh tweet mediaNeil Ghosh tweet media
English
1
0
1
94
MKD @ 127.0.0.1 2x💉 🍉
@neilghosh People trying to spin-up their own E2EE is most stupidest shit I have seen. Understand, use the existing framework or algo. If you can sponsor some of them.
English
0
0
0
17
Neil Ghosh
Neil Ghosh@neilghosh·
For personal experience sometimes we spend more than half of the time rather than feature development . No doubt it’s hard but ( customer )trust once lost harder to get back , let alone legal consequences
Kamalesh@kamaleshanirudh

Disappointed by the lack of response from @Arattai regarding a critical E2EE privacy bug I discovered.Reporting via support leads to generic replies with 0 interest in the technical details. open challenge to the @Arattai team and @svembu sir

English
1
0
1
69
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
Scott Ullrich
Scott Ullrich@sullrich·
I co-founded pfSense. For the last year I've been building its successor. If you run pfSense today, you already know the reasons to look around: development you can't influence, a CE edition that feels like an afterthought, FreeBSD driver roulette on modern hardware, and a config workflow where one bad apply on a remote box means a drive. nfSensei is my answer. Built from scratch in Rust, on Linux, and designed around the things pfSense users actually complain about. Your config.xml imports. There's an importer that reads your pfSense config, shows you exactly what maps over and what needs attention, then applies it. You don't start from zero. You can't brick it from the couch. Changes stage as a candidate, diff before apply, validate through the real engines before anything is written, and auto-roll-back if you don't confirm in time. If a config ever fails at boot, the box falls back to the last good one on its own. The hardware works. Linux base means modern NICs and drivers just work — and the fast path compiles your rules to XDP at 40Gbps. Automation is native, not scraped. Everything the UI does is a documented API call — about 1,140 of them, with a built-in explorer. Your Ansible finally gets a real interface. The VPNs are current. WireGuard, IPsec, Tailscale, and self-hosted mesh — your own control plane, your keys — plus post-quantum key exchange where it counts. The experimental stuff has its own wing. Thirty-plus Labs features behind toggles: WAN bonding that fuses multiple cheap uplinks through a $5 VPS into one resilient pipe, per-flow SLA telemetry with tamper-evident audit chains, GeoDNS that steers traffic by live RTT and load, application-aware QoS, config push to a whole fleet of remote nodes, and an AI assistant on the box that reads your actual interfaces and logs using local models. Toggles are per-browser and can't touch your running config — flip things on, break them, tell me about it. Oh, and there is much more to mention here! Self-hosted, on your hardware, no cloud account, no subscription. It's NOW IN ACTIVE BETA (previously alpha) with about 40 testers, and bug reports typically get fixed in days. I want more people who know what pfSense does well and can tell me exactly where nfSensei falls short. If you are interested in testing please email me: sullrich@gmail.com. Tell me about your pfSense setup and I'll get you access. Note: Affiliates and employees of Netgate are not invited.
English
146
323
2.7K
182.8K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
Dear friends, something important. One of the biggest promoters of pseudoscience and unscientific medical practices globally is The World Health Organization. Like this recent post of theirs on the Chinese rubbish known as Acupuncture: instagram.com/p/DaUsDnqG-nT/ We wrote an invited and important Editorial for the BMJ on how the WHO's direct and indirect promotions of complementary and alternative medicine using "Global Strategies" targeting countries were pseudoscientific integrative medicine is easily promoted, is causing chaos, confusion and patient harms. It is time these so-called medical organizations took a real stand against "false medicine." This Editorial in the BMJ is now free for all to read - please do check it out: bmj.com/content/393/bm… and share with your friends, family and colleagues. Patients deserve science-based medicine. And nothing less. @CaulfieldTim @Cath77777 @WHO
TheLiverDoc™ tweet media
English
8
91
400
21.3K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
Tuta
Tuta@TutaPrivacy·
Tuta's One-Click Migration is now in closed beta 🎉🥳 Switching to Tuta is only getting easier because with this new migration feature you can: ✅️ Automatically migrate and sync any old external mailboxes (with IMAP) into Tuta Mail. This means that if you or your business would like to switch to Tuta Mail and bring all existing emails and folders with, it will soon be an automated and hassle-free process. 😎🔥 That's not all that's new & improved! Find out more 👉 tuta.com/blog/tuta-one-…
Tuta tweet media
English
5
12
118
5.7K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
I have some major news for you. In a nutshell: The researchers misled the public by using mathematically impossible data to artificially inflate the effectiveness of a papaya leaf extract. In their published study, the authors divided patients into different analysis groups, specifically defining a smaller group of patients as a strict subset of a larger group. However, the authors reported a higher number of recovered patients in the smaller group than in the larger one, which is a glaring arithmetic impossibility. This manipulated mathematical error was only applied to the placebo group, effectively shrinking the placebo's success rate so the papaya treatment would look successful by comparison. When the data is looked at honestly - including all randomized patients without artificially excluding anyone - the extract showed absolutely no benefit at any point during the trial. Furthermore, the researchers changed their own methodical rules after the fact, to hide the treatment's overall failure. The trial was officially registered beforehand to measure patient recovery by Day 7 of the study. Because the papaya extract failed to show any significant benefit by that pre-planned deadline, the authors completely shifted the goalposts, falsely presenting Day 4 as their primary focus in the final publication just to highlight their manipulated data. On top of these changing rules, the researchers broke their own eligibility guidelines by including nearly 40% of patients who did not even meet the correct cancer stage requirements to be in the study. Ultimately, the study's positive conclusions are entirely unsupported and dangerous, potentially tricking vulnerable patients into using an unproven extract instead of reliable medical care.
TheLiverDoc™ tweet media
English
37
244
1.2K
71K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
Dear Hepatology friends, and people caring for liver patients, we have a new paper out. Living with chronic liver disease can be incredibly overwhelming, and trying to navigate which supplements actually work can be just as confusing. Our study looking at glutathione, a very popular antioxidant supplement often prescribed for liver health, has just challenged the traditional "one-size-fits-all" approach to treatment. Instead of finding that glutathione works for everyone, we discovered that the supplement's effectiveness depends heavily on how sick the patient currently is. Here is the lay summary: ⭐Sicker patients actually improved more: Counter-intuitively, patients who were acutely ill with active, severe inflammation responded much better to glutathione than patients with stable liver disease. ⭐Longer treatment isn't always better: Taking glutathione for extended periods of time (beyond 15-day) did not provide any extra clinical benefit or improve survival. ⭐The "Ideal" patient profile: The highest success rates (where 70.5% of patients improved - with respect to disease severity) were seen in a very specific group: younger patients (under 60) with alcohol-associated liver disease, high active disease severity (MELD-3 score above 18), but who still had some baseline preserved liver function (albumin levels above 2.5). ⭐Inflammation is the key tracker: Patients whose inflammation markers (like C-reactive protein, or CRP) dropped during the treatment saw the most dramatic improvements in their overall liver disease scores and had much lower hospitalizations. For a long time, there has been a habit of indiscriminately prescribing glutathione to anyone with liver disease. This study strongly pushes back against that practice. Instead, it promotes a precision-medicine approach. Limitation: Because this study looked backward at past medical records (a retrospective study) without a placebo group, we cannot definitively prove that the supplement alone caused the improvements. To move forward, the medical community needs to conduct a rigorous, prospective randomized controlled trial. This future trial should specifically test glutathione versus a placebo on the "ideal" high-risk patients who have active systemic inflammation. Additionally, future researchers must measure specific, direct markers of oxidative stress in the blood to definitively prove that the supplement is working biologically the way we think it is. Full paper link: frontiersin.org/journals/pharm… via @FrontiersIn and @FrontPharmacol
TheLiverDoc™ tweet media
English
10
41
239
23.6K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
Today is National Doctors Day in India. And the best day for me to discuss this very important paper. I will tell you why, at the end of this post. The BMJ invited me to lead and write an invited editorial with a niche group of medical science communicators on an important topic. bmj.com/content/393/bm… One of the most common arguments from the traditional medicine industry to prove the "legitimacy" of their (untested) products and (unscientific) practices in healthcare was that they had been "recognised" by WHO. Large scale global meetings were conducted by WHO. And countries with emotional appeal towards traditional medical care, while others with political, religious and cultural stakes in the form of business oppurtunities were all part of these WHO-driven meetings were public funds were utilized to plan strategies to justify alternative medicine and promote it. In this invited review, me, along with fantastic and brilliant medical science communicators - @CaulfieldTim , @Cath77777 , Prof. Xingshun Qi - and a patient-partner discuss, how, some WHO-related strategies, policies and endoresements are not science-related, but mostly politically and culturally motivated. Please read here: bmj.com/content/393/bm… 4 major points about the risks of rushing alternative medicine: Lowered scientific tandards: The WHO is pushing to include traditional and alternative medicines into standard healthcare systems. However, they are dangerously lowering the scientific standards needed to prove these treatments actually work, allowing them to be endorsed before standard safety data exists. Real risks to patients: Rushing to use unproven traditional remedies can lead to serious patient harm, including dangerous interactions with standard medications. Globally, herbal remedies are actually a more common cause of severe liver failure than prescription drugs. Driven by politics, not science: The growing acceptance of alternative medicine is often driven by politics, nationalism, and economic interests rather than reliable science. Promoting these unproven practices risks spreading health misinformation and commercially exploiting vulnerable patients. Safety must come first: While traditional practices are heavily relied upon globally, all patients deserve treatments that are fundamentally safe and effective. We must ensure alternative medicines pass the exact same rigorous scientific tests as conventional healthcare before endorsing them. Today is National Doctors Day in India. Whether is is WHO or any such "legit" monolithic organization directly promoting misinformation and indirectly driving disinformation that can cause public health harm, as doctors, we do not look at the size of different Goliaths we meet. We fight like David, to protect - because that is what doctors who are really teachers swore - took an oath - that Primum non nocere... ..."first, do no harm." We hope the WHO is listening. And so are the public. Editorial: WHO’s misguided push for complementary and alternative medicine bmj.com/content/393/bm…
TheLiverDoc™ tweet media
English
24
143
691
32.7K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
Something important. Dear friends, my recently concluded talk is now available to watch on YouTube. Before I started my session, I put out a disclaimer that alternative medicine practitioners seated in the audience might find my talk extremely triggering. This is one session I thought would be taken down by alternative medicine (Ayush) regulators in India... ...because I do not mince my words at all, about the massive public-fund wastage called Ayush. For students who are planning to join Ayurveda or Homeopathy or such Ayush-related colleges for professional training... or those parents who are planning to send their children to Ayush - especially Ayurveda-related professional colleges to make a career out of it, this video will mess up your mind - and rightly so. This is one video, which I would like everyone to watch, share and promote.... especially among those trying to get into alternative medicine colleges in India as a career option because they will be given the title of 'Dr". Let us stop wasting our childrens future in India by sending them to a career of deceit and fraud - in alternative medicine - just for the legal (but never practical or logical) 'Dr' title. Sacred Poisons | The Liver Doc | RenaiESSENSE'26 youtu.be/jQDmse4Jod0 via @esSENSEGlobal
YouTube video
YouTube
TheLiverDoc™ tweet media
English
14
194
863
79.2K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
Every medical science communicator must help prevent pseudoscience from infiltrating credible science databases. theprint.in/feature/liverd…
English
23
219
1.2K
26.4K
Vitto Rivabella
Vitto Rivabella@VittoStack·
Creating a PRIVATE Discord server for people to learn about AI security and alignment. We’ll talk about what we’re learning, resources, favorite AI security tools, jailbreaking techniques, AI alignment new releases, courses, X, etc. Comment if you want to join. We will reach out.
English
682
10
385
66.9K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
Flipper R&D
Flipper R&D@Flipper_RND·
Please help us verify a WiFi chip for Flipper One. We chose the Mediatek MT7921AU as Flipper One’s built-in Wi-Fi chip because it’s the most advanced hacker-friendly chipset we could find. It supports 2.4/5/6 GHz operation, monitor mode, packet injection, and has an open-source driver in the mainline Linux kernel. The Alfa AWUS036AXML has the same chipset. However, we couldn’t make a few basic features work: ∙Simultaneous client (STA) and hotspot (AP) modes (for example, to proxy a paid Wi-Fi network). ∙Dual-band AP on 2.4 GHz and 5 GHz at the same time (to create a highly-compatible Wi-Fi hotspot). The datasheet and driver data contradict each other, and it seems that these features must work. We don’t understand whether we're hitting software or hardware limitations. So we ask for your help. Our Wi-Fi module specifications: docs.flipper.net/one/hardware/w…. To participate in testing, edit this page: docs.flipper.net/one/testing/ne…. #FlipperHelpWanted
Flipper R&D tweet media
English
21
39
576
50.6K
Gaurav Sabnis
Gaurav Sabnis@gauravsabnis·
Hahaha apparently this is being sent around as "proof" that I'm "secretly gay". 😂 A picture from my own Twitter account, with my wife, at the NYC pride parade. Oh sanghis! 😂 (Sorry for the chest hair display. I didn't plan to be in a tank that day. It just got too hot!)
Gaurav Sabnis tweet media
English
22
14
383
16K
Arnav Gupta
Arnav Gupta@championswimmer·
TCS/Infy or even Zoho, Jio have the ability to run an inference datacenter in India. (Running inference with open models like Kimi/GLM/Qwen/DeepSeek) is a valuable and valid business. Tons of companies in US/EU/SG doing it. But we don't and we can't because a) those with capacity don't have the ability to understand this opportunity b) power is still very costly in India and that's not great if India wants to grow c) infra projects are hard to do without tying up with existing oligarchs and paying out a lot of bribes d) some among of unnecessary sinophobia with using Chinese models (it is open weights you can download and even remove Chinese political guardrails if you want to)
Upamanyu Acharya@upamanyuacharya

I use 1B+ tokens a month on AI and not one rupee of it stays in India. That, not the Fable ban, is the real sovereignty problem. A sovereign model is the one layer of this entire stack we could have cloned in a weekend. Weights are downloadable; Deepseek, Kimi and GLM already proved frontier-grade intelligence is a few thousand GPU-hours and an RLHF pipeline away. The layers underneath the model - power, copper, fabrication, ports, rare earths - are where India has ZERO position, and no amount of national pride changes that. Quick recap for anyone who missed it: on 12 June the US Commerce Department slapped an export-control order on Fable 5 and Mythos 5, three days after Anthropic shipped them. It covered every foreign national, including Anthropic's own non-US staff, so the only compliant move was to kill both models globally. India is reportedly their 2nd largest market, which is why the good folks on X went crazy. 5 things are true at once, and the panic flattens them into a single grievance: 1. This is bullish for open weights, not bearish. Take one frontier lab off the board and demand doesn't vanish; it reroutes to the next lab on the pareto frontier of cost x performance. I run 10x the token volume on Deepseek as I do on Opus despite paying for the $100 Claude plan, because it gets me ~90% of the output at a 1000x less the cost. Pure Jevons paradox: token cost falls 100x, usage spikes >100x, the price elasticity of intelligence is effectively infinite. The VCs aren't the subsidy anymore; the heavy users are the revenue. 2. Every input I pay for sits outside the country. Power from US gas, solar, wind. GPUs the Taiwanese built from rare earths which China rations. Substrates and optics from Japan. Racks built by Dell and SMIC. Data centres in Texas and Virginia. My AI bill has the lowest domestic value capture of anything I buy - pure dollar outflow that leaves and never comes back. 3. Blaming Infosys and TCS for not building a lab is lazy. Vishal Sikka pointed Infosys at roughly this future and got pushed out in 2017; the forward-leaning bet left with him. With hindsight it's one of the most expensive governance calls in Indian corporate history. But it's a symptom of the incentive structure, not the cause. 4. Even with a sovereign model, it wouldn't matter. Under 100 million Indians have ever used an AI that Google doesn't serve them for free. The number willing to pay tens of dollars a month is a few million. You cannot underwrite frontier-scale capex against that base. 5. This is a sequencing problem decades deep. While the Dutch were spinning ASML out of Philips with Carl Zeiss optics, HMT was importing watch movements from Citizen and Seiko because we couldn't cut our own steel accurately. My grandparents in Calcutta queued hours, several times a week, for baby formula at the same time Shenzhen was growing its economy ten-thousand-fold in 40 years by letting free markets run; we spent the same decades dismantling a licence raj that still isn't gone.

English
25
51
507
66.7K
Chirag Barjatya
Chirag Barjatya@chiragbarjatya·
@NordVPN how come India is not listed in the tax country while making payment?
English
8
0
76
15.2K
MKD @ 127.0.0.1 2x💉 🍉 retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
Doctors are not asking for integration of alternative medicine into the standard of care. Patients are not asking for integration of alternative medicine into the standard of care. The public is not asking for integration of alternative medicine into the standard of care. The only people asking for integrative medicine are alternative medicine practitioners, their promoters and sympathizers for survival and business opportunities. The only way alternative medicine can survive into the distant future is by integration into standard medical care and these quacks know it. Don't fall for this nonsense.
English
33
223
1.1K
39.1K